<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a 43-year-old male patient with congenital <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> requiring hemodialysis due to extension of venous <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> from <z:hpo ids='HP_0004850'>recurrent deep vein thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>During dialysis with adequate heparinization, the patient often revealed clot formation in the extracorporeal circuit resulting in unexpected discontinuation of dialysis </plain></SENT>
<SENT sid="2" pm="."><plain>When either a combination of antithrombin III concentrate + <z:chebi fb="5" ids="28304">heparin</z:chebi> or the newly developed synthetic antithrombin preparation, MD805, was administered during dialysis, he could be uneventfully dialyzed with either of the two regimens </plain></SENT>
</text></document>